VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_18-vv-01920
Package ID: USCOURTS-cofc-1_18-vv-01920
Petitioner: C.H.
Filed: 2018-12-14
Decided: 2021-12-08
Vaccine: hepatitis B
Vaccination date: 2017-03-06
Condition: idiopathic thrombocytopenic purpura (ITP)
Outcome: compensated
Award amount USD: 7632

AI-assisted case summary:
On December 14, 2018, C.H., the parent of minor I.H., filed a petition for compensation alleging that the hepatitis B and inactivated polio (IPV) vaccines, administered to I.H. on March 6, 2017, caused him to develop idiopathic thrombocytopenic purpura (ITP). The petition stated that I.H. suffered residual effects from this injury for more than six months. The respondent, the Secretary of Health and Human Services, denied that the vaccines caused I.H.'s condition. Despite the respondent's denial, the parties filed a joint stipulation agreeing to compensation. Special Master Christian J. Moran found the stipulation reasonable and adopted it as the court's decision. The award included a lump sum payment of $7,632.84 to reimburse a lien for services rendered by Wellcare, a Medicaid plan, payable jointly to petitioner and Equian. An additional amount was awarded to purchase an annuity contract. These amounts represent all other damages available under the program. The decision was originally filed on November 3, 2021, and reissued on December 8, 2021. Petitioner's counsel was Ronald C. Homer of Conway, Homer, P.C., and respondent's counsel was Ronalda E. Kosh of the United States Department of Justice. The public decision does not describe the specific onset of symptoms, diagnostic tests, treatments, or the medical experts consulted.

Theory of causation field:
Petitioner alleged that the hepatitis B and inactivated polio (IPV) vaccines, received on March 6, 2017, caused I.H. to develop idiopathic thrombocytopenic purpura (ITP), with residual effects lasting more than six months. The respondent denied causation. The parties reached a joint stipulation for compensation, which was adopted by Special Master Christian J. Moran. The stipulation was found reasonable and resulted in an award of $7,632.84 for reimbursement of a lien for services rendered by Wellcare, and an additional amount to purchase an annuity contract. The theory of causation was based on the Vaccine Injury Table. The public decision does not detail the specific mechanism of injury, expert testimony, or the evidence considered beyond the stipulation.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_18-vv-01920-0
Date issued/filed: 2021-12-08
Pages: 10
Docket text: PUBLIC DECISION (Originally filed: 11/03/2021) regarding 78 DECISION Stipulation/Proffer. Signed by Special Master Christian J. Moran. (jmw) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-01920-UNJ Document 85 Filed 12/08/21 Page 1 of 10
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
* * * * * * * * * * * * * * * * * * * * *
C.H., *
parent of I.H., a minor, *
* No. 18-1920V
Petitioner, * Special Master Christian J. Moran
*
v. * Filed: November 3, 2021
* Reissued: December 8, 2021
SECRETARY OF HEALTH *
AND HUMAN SERVICES, * Stipulation; Hepatitis B vaccine;
* inactivated polio (“IPV”); idiopathic
* thrombocytopenic purpura (“ITP”).
Respondent. *
* * * * * * * * * * * * * * * * * * * * *
Ronald C. Homer, Conway, Homer, P.C., Boston, MA, for Petitioner;
Ronalda E. Kosh, United States Dep’t of Justice, Washington, DC, for Respondent.
UNPUBLISHED DECISION1
On November 3, 2021, the parties filed a joint stipulation concerning the
petition for compensation filed by C.H. on December 14, 2018. In her petition,
petitioner alleged that the hepatitis B and inactivated polio (“IPV”) vaccines,
which are contained in the Vaccine Injury Table (the “Table”), 42 C.F.R. §
100.3(a), and which I.H. received on March 6, 2017, caused I.H. to suffer
idiopathic thrombocytopenic purpura (“ITP”). Petitioner further alleges that I.H.
suffered the residual effects of this injury for more than six months. Petitioner
represents that there has been no prior award or settlement of a civil action for
damages on behalf of I.H. as a result of his condition.
Respondent denies that the vaccines caused I.H. to suffer from ITP or any
other injury.
1 Pursuant to Vaccine Rule 18(b), C.H. filed a motion to redact her name from the
decision. This motion was granted and the decision is being otherwise released to the public.

Case 1:18-vv-01920-UNJ Document 85 Filed 12/08/21 Page 2 of 10
Nevertheless, the parties agree to the joint stipulation, attached hereto. The
undersigned finds said stipulation reasonable and adopts it as the decision of the
Court in awarding damages, on the terms set forth therein.
Damages awarded in that stipulation include:
a. A lump sum payment of $7,632.84, which amount represents
reimbursement of a lien for services rendered on behalf of I.H. by
Wellcare, a Medicaid plan, in the form of a check payable jointly to
petitioner and Equian, and mailed to:
Equian
P.O. Box 182643
Columbus, OH 43218
Tax ID #: 27-0083277
Equian Event Number: 45764645
Legacy Case Number: 995746
Attn: Michael Zyrowski
b. An amount sufficient to purchase the annuity contract described in
paragraph 10 of the stipulation, paid to the life insurance company
from which the annuity will be purchased (the “Life Insurance
Company”).
These amounts represent all other damages that would be available
under 42 U.S.C. § 300aa-15(a).
In the absence of a motion for review filed pursuant to RCFC, Appendix B,
the clerk is directed to enter judgment according to this decision and the attached
stipulation.2
IT IS SO ORDERED.
s/Christian J. Moran
Christian J. Moran
2 Pursuant to Vaccine Rule 11(a), the parties can expedite entry of judgment by each
party filing a notice renouncing the right to seek review by a United States Court of Federal
Claims judge.
2

Case 1:18-vv-01920-UNJ Document 85 Filed 12/08/21 Page 3 of 10
Special Master
3

Case 1:18-vv-01920-UNJ Document 85 Filed 12/08/21 Page 4 of 10

Case 1:18-vv-01920-UNJ Document 85 Filed 12/08/21 Page 5 of 10

Case 1:18-vv-01920-UNJ Document 85 Filed 12/08/21 Page 6 of 10

Case 1:18-vv-01920-UNJ Document 85 Filed 12/08/21 Page 7 of 10

Case 1:18-vv-01920-UNJ Document 85 Filed 12/08/21 Page 8 of 10

Case 1:18-vv-01920-UNJ Document 85 Filed 12/08/21 Page 9 of 10

Case 1:18-vv-01920-UNJ Document 85 Filed 12/08/21 Page 10 of 10